Difference between revisions of "Team:Glasgow/Interlab"
(68 intermediate revisions by 3 users not shown) | |||
Line 384: | Line 384: | ||
<tr><td class="survivability">Equipment</td></tr> | <tr><td class="survivability">Equipment</td></tr> | ||
<tr><td class="conclusion">Methodology</td></tr> | <tr><td class="conclusion">Methodology</td></tr> | ||
− | <tr><td class="firstuse">Measurements</td></tr> | + | <tr><td class="firstuse">Sequencing</td></tr> |
− | <tr><td class="contamination"> | + | <tr><td class="discuss">Measurements</td></tr> |
+ | <tr><td class="contamination">Conclusion</td></tr> | ||
<tr><td class="top">Top</td></tr> | <tr><td class="top">Top</td></tr> | ||
</table> | </table> | ||
Line 414: | Line 415: | ||
<div class="text"> | <div class="text"> | ||
</br> | </br> | ||
− | Charlotte Flynn - Carried out cloning of devices, measurements of devices and completed the relevant forms and content of wiki page. </div> | + | <b>Charlotte Flynn</b> - Carried out cloning of devices, measurements of devices and completed the relevant forms and content of wiki page. </div> |
</div> | </div> | ||
</br> | </br> | ||
Line 421: | Line 422: | ||
<div class="text"> | <div class="text"> | ||
</br> | </br> | ||
− | Sean Colloms - Supervisor for the InterLab study. Helped with cloning devices, taking measurements of the devices and editing the wiki page. | + | o Sean Colloms - Supervisor for the InterLab study. Helped with cloning devices, taking measurements of the devices and editing the wiki page. |
</br> | </br> | ||
− | Vilija Lomeikaite - Set up overnight cultures of the devices | + | o Vilija Lomeikaite - Set up overnight cultures of the devices |
</br> | </br> | ||
− | Ye Yang - Designed and formatted the Interlab wiki page | + | o Ye Yang - Designed and formatted the Interlab wiki page |
</br> | </br> | ||
− | Andrey Filipov - Carried out the calibration measurements for the spectrophotometer | + | o Andrey Filipov - Carried out the calibration measurements for the spectrophotometer |
</br> | </br> | ||
− | James Provan - Sent cloned devices for sequencing </div> | + | o James Provan - Sent cloned devices for sequencing </div> |
</div> | </div> | ||
</br> | </br> | ||
Line 436: | Line 437: | ||
<div class="text"> | <div class="text"> | ||
</br> | </br> | ||
− | The cloning of devices was carried out from the 17 – 21st of August. Measurements of the devices were carried out from the 24th– 28th of August. Detailed | + | The cloning of devices was carried out from the 17 – 21st of August. Measurements of the devices were carried out from the 24th– 28th of August. <div class="box5" style="background-color:#FFFFAD;"> |
+ | <h5> | ||
+ | Detailed Lab Book | ||
+ | </h5> | ||
+ | <div class="text"> | ||
+ | o <b>17/08/2015 (Day 1)</b> - Made TOP-10 competent cells using overnights. Got the parts J23101, J23106, J23117, I13504, I20270 and R0040 off the iGEM distributions plates. Transformed the resuspended DNA into the competent cells, plated them with the appropriate antibiotic and grew them overnight. | ||
+ | </br> | ||
+ | o <b>18/08/2015 (Day 2)</b> - Picked a single colony of each part, inoculated broth and grew over night. | ||
+ | </br> | ||
+ | o <b>19/08/2015 (Day 3)</b> - Carried out mini preps of each part from overnights and made glycerol stocks. Digested promoters J23101, J23106 and J23117 with Pst1 and Spe1 and I13504 with Xba1 and Pst1. J23106 and I13504 didn't cut correctly therefore set up more overnights to repeat digestion. | ||
+ | </br> | ||
+ | o <b>20/08/2015 (Day 4)</b> - Carried out mini preps I13504 and J23106 and re digested each part. Carried out gel extractions, purifications and ligated each promoter to the GFP part I13504. Set up over nights of TOP-10. | ||
+ | </br> | ||
+ | o <b>21/08/2015 (Day 5)</b> - Transformed TOP-10 cells with each device (I13504:J23101, I13504:J23106 and I13504:J23117) and positive/negative controls and plated them. | ||
+ | </br> | ||
+ | o <b>24/08/2015 (Day 6)</b> - Set up overnights and restreaks of 1 colony of each device. | ||
+ | </br> | ||
+ | o <b>25/08/2015 (Day 7)</b> - Prepared samples of each device and controls for measurement by two methods; measuring the A600 of devices in broth and diluting to 0.5 and diluting samples of devices in PBS and measuring their A600 to determine to most accurate method. | ||
+ | </br> | ||
+ | o <b>26/08/2015 (Day 8)</b> - Set up overnights of colony 1,2 and 3 of each device, positive and negative control and technical replicants. | ||
+ | </br> | ||
+ | o <b>27/08/2015 (Day 9)</b> - Carried out mini preps of colony 1 of each device and controls and sent for sequencing. Prepared samples of each device (colony1-3) for measurement along with two technical replicants using the PBS method. Carried out GFP fluorescence readings on a 96 well plate of each device, positive and negative control and a dilution series of LOV proteins and FAM labelled oligonucleoutide. | ||
+ | </br> | ||
+ | o <b>28/08/2015 (Day 10)</b> - Calculated absolute values of fluorescence of GFP and submitted the completed InterLab Worksheet and Protocol forms. | ||
+ | </br> | ||
+ | o <b>31/08/2015 -13/08/2015</b> – Completed wiki page. | ||
+ | </br> | ||
+ | </div> | ||
+ | </div> | ||
+ | </br> | ||
+ | </div> | ||
</div> | </div> | ||
<div class="scrollSurvivability"></div> | <div class="scrollSurvivability"></div> | ||
Line 449: | Line 480: | ||
Model and manufacturer: | Model and manufacturer: | ||
<br> | <br> | ||
− | o Incubator – 2cm shaking diameter | + | o <b>Incubator</b> – 2cm shaking diameter |
</br> | </br> | ||
− | o Spectrophotometer – Used to measure absorbance at 600nm of each sample. | + | o <b>BioMate™ 3S Spectrophotometer: Life Science Analyzer</b> – Used to measure absorbance at 600nm of each sample. |
</br> | </br> | ||
− | o Typhoon FLA 9500 | + | o <b>Typhoon FLA 9500: GE Healthcare Life Sciences</b> - Wavelength used to excite cells - 475nm. Filter/channel used to capture the light emission from the cells - Filter BPB1 (530DF20). |
</div> | </div> | ||
</div> | </div> | ||
Line 463: | Line 494: | ||
In order to calibrate the spectrophotometer a dilution series of 1-100% of DH5 alpha cells was carried out and the A600 of each sample was measured (Figure 1). | In order to calibrate the spectrophotometer a dilution series of 1-100% of DH5 alpha cells was carried out and the A600 of each sample was measured (Figure 1). | ||
</br> | </br> | ||
− | <img src="https://static.igem.org/mediawiki/2015/ | + | </figure></center> |
− | <figcaption>Figure 1: Spectrophotometer calibration curve | + | <br> |
+ | <center><figure> <img src="https://static.igem.org/mediawiki/2015/0/07/2015-Glasgow-interlab36.png"> | ||
+ | <figcaption><b>Figure 1</b>: Spectrophotometer calibration curve | ||
</figcaption> | </figcaption> | ||
</br> | </br> | ||
Line 476: | Line 509: | ||
A dilution series was measured for phiLOV protein (Figure 2), converted to numerical readings (Table 1) and a calibration curve (Figure 3) carried out to calibrate the Typhoon. Fluorescent proteins derived from voltage (LOV) domains are smaller and more efficient under anaerobic conditions than green fluorescent proteins (GFP) (Buckley et, al. 2015). iLOV, an improved LOV flavoprotein, was originally engineered as a reporter for viral infection from phototropin, the blue light receptor. We used phiLOV which is a photostable version of the iLOV fluorescence reporter. | A dilution series was measured for phiLOV protein (Figure 2), converted to numerical readings (Table 1) and a calibration curve (Figure 3) carried out to calibrate the Typhoon. Fluorescent proteins derived from voltage (LOV) domains are smaller and more efficient under anaerobic conditions than green fluorescent proteins (GFP) (Buckley et, al. 2015). iLOV, an improved LOV flavoprotein, was originally engineered as a reporter for viral infection from phototropin, the blue light receptor. We used phiLOV which is a photostable version of the iLOV fluorescence reporter. | ||
</br> | </br> | ||
− | <img src="https://static.igem.org/mediawiki/2015/6/62/2015-Glasgow-interlab1.png"> | + | </figure></center> |
− | <figcaption>Figure 2: Fluorescence readings of a dilution series of phiLOV. 67.5µg = 67.5µg phiLOV in 100µl PBS. Each concentration was carried out twice. | + | <br> |
+ | <center><figure> <img src="https://static.igem.org/mediawiki/2015/6/62/2015-Glasgow-interlab1.png"> | ||
+ | |||
+ | <figcaption><b>Figure 2</b>: Fluorescence readings of a dilution series of phiLOV. 67.5µg = 67.5µg phiLOV in 100µl PBS. Each concentration was carried out twice. | ||
</figcaption> | </figcaption> | ||
</br> | </br> | ||
<img src="https://static.igem.org/mediawiki/2015/a/af/2015-Glasgow-interlab3.png" height='60%' width='60%'/> | <img src="https://static.igem.org/mediawiki/2015/a/af/2015-Glasgow-interlab3.png" height='60%' width='60%'/> | ||
− | <figcaption>Table 1: Summary of the fluorescence readings of phiLOV protein. | + | <figcaption><b>Table 1</b>: Summary of the fluorescence readings of phiLOV protein. |
</figcaption> | </figcaption> | ||
</br> | </br> | ||
<img src="https://static.igem.org/mediawiki/2015/b/b8/2015-Glasgow-interlab2.png" height="60%" width="60%"/> | <img src="https://static.igem.org/mediawiki/2015/b/b8/2015-Glasgow-interlab2.png" height="60%" width="60%"/> | ||
− | <figcaption>Figure 3: Calibration curve of fluorescence of phiLOV | + | <figcaption><b>Figure 3</b>: Calibration curve of fluorescence of phiLOV |
</figcaption> | </figcaption> | ||
</div> | </div> | ||
Line 500: | Line 536: | ||
The devices, as shown in Table 2, were prepared using BioBrick assembly. Parts J23101, J23106, J23117, I13504, I20270 and R0040 were taken from the iGEM distribution plates and each transformed into TOP-10 competent cells. The promoters were digested with Pst1 and Spe1 and the GFP part, I13504, was digested with Xba1 and Pst1. The I13504 part was then ligated into each promoter plasmid and transformed into TOP-10 cells to create the three required devices in pSB1C3 (Figure 4). Restreaks were carried out for one colony of each device and control and three colonies of each (labelled 1, 2 and 3) were picked and grown separately. Sequencing was carried out to check the correct devices had been created. | The devices, as shown in Table 2, were prepared using BioBrick assembly. Parts J23101, J23106, J23117, I13504, I20270 and R0040 were taken from the iGEM distribution plates and each transformed into TOP-10 competent cells. The promoters were digested with Pst1 and Spe1 and the GFP part, I13504, was digested with Xba1 and Pst1. The I13504 part was then ligated into each promoter plasmid and transformed into TOP-10 cells to create the three required devices in pSB1C3 (Figure 4). Restreaks were carried out for one colony of each device and control and three colonies of each (labelled 1, 2 and 3) were picked and grown separately. Sequencing was carried out to check the correct devices had been created. | ||
</br> | </br> | ||
− | <img src="https://static.igem.org/mediawiki/2015/7/70/2015-Glasgow-interlab4.jpg" height="40%" width="40%"/> | + | </figure></center> |
− | <figcaption>Table 2: Summary of BioBrick used</figcaption> | + | <br> |
+ | <center><figure> <img src="https://static.igem.org/mediawiki/2015/7/70/2015-Glasgow-interlab4.jpg" height="40%" width="40%"/> | ||
+ | <figcaption><b>Table 2</b>: Summary of BioBrick used</figcaption> | ||
</br> | </br> | ||
<img src="https://static.igem.org/mediawiki/2015/2/21/2015-Glasgow-interlab5.png" height="60%" width="60%"/> | <img src="https://static.igem.org/mediawiki/2015/2/21/2015-Glasgow-interlab5.png" height="60%" width="60%"/> | ||
− | <figcaption>Figure 4: Device cloning strategy</figcaption> | + | <figcaption><b>Figure 4</b>: Device cloning strategy</figcaption> |
</div> | </div> | ||
</div> | </div> | ||
Line 512: | Line 550: | ||
<div class="text"> | <div class="text"> | ||
</br> | </br> | ||
− | Overnight cultures of colony 1-3 of each device were set up (in Luria broth with chloramphenicol) to provide 1ml for measuring on a 96-well plate. As the | + | Overnight cultures of colony 1-3 of each device were set up (in Luria broth with chloramphenicol) to provide 1ml for measuring on a 96-well plate. As the lb broth gave noticeable background fluorescence samples were also prepared by spinning down cells, in the overnight cultures, to pellets and resuspending in PBS (phosphate buffered saline). It was determined the PBS method gave the most accurate measurements so readings were taken using this method for all three biological replicates and technical replicates. </br> |
</br> | </br> | ||
The recipe used for a 1 x solution of PBS was 8g NaCl, 0.2g KCl, 1.44g Na2HPO4 and 0.24g KH2PO4 dissolved in 800ml of H2O, the pH adjusted to 7.4 and the final volume made up to 1 litre with distilled H2O. </div> | The recipe used for a 1 x solution of PBS was 8g NaCl, 0.2g KCl, 1.44g Na2HPO4 and 0.24g KH2PO4 dissolved in 800ml of H2O, the pH adjusted to 7.4 and the final volume made up to 1 litre with distilled H2O. </div> | ||
Line 541: | Line 579: | ||
A dilution series of FAM labelled oligonucleotide was measured (Figure 5) and converted to numerical readings (Table 3) to enable absolute values for the devices to be calculated. The calibration curve (Figure 6) has a line gradient of 4.79x10^6. Therefore the fluorescence readings of the devices will be divided by the conversion factor of 4,790,000 to give absolute fluorescence as equivalent to pmol of FAM labelled oligonucleotide. Absolute values should be comparable across different equipment and protocols. | A dilution series of FAM labelled oligonucleotide was measured (Figure 5) and converted to numerical readings (Table 3) to enable absolute values for the devices to be calculated. The calibration curve (Figure 6) has a line gradient of 4.79x10^6. Therefore the fluorescence readings of the devices will be divided by the conversion factor of 4,790,000 to give absolute fluorescence as equivalent to pmol of FAM labelled oligonucleotide. Absolute values should be comparable across different equipment and protocols. | ||
</br> | </br> | ||
− | <img src="https://static.igem.org/mediawiki/2015/8/8d/2015-Glasgow-interlab6.png"> | + | </figure></center> |
− | <figcaption>Figure 5: Fluorescence readings of a dilution series of FAM labelled oligonucleotide. 10pmol = 10pmol FAM labelled oligonucleotide in 100µl PBS.</figcaption> | + | <br> |
+ | <center><figure><img src="https://static.igem.org/mediawiki/2015/8/8d/2015-Glasgow-interlab6.png"> | ||
+ | <figcaption><b>Figure 5</b>: Fluorescence readings of a dilution series of FAM labelled oligonucleotide. 10pmol = 10pmol FAM labelled oligonucleotide in 100µl PBS.</figcaption> | ||
</br> | </br> | ||
<img src="https://static.igem.org/mediawiki/2015/f/f2/2015-Glasgow-Interlab20.png" height="60%" width="60%"> | <img src="https://static.igem.org/mediawiki/2015/f/f2/2015-Glasgow-Interlab20.png" height="60%" width="60%"> | ||
− | <figcaption>Table 3: Fluorescence readings of FAM labelled oligonucleotide.</figcaption> | + | <figcaption><b>Table 3</b>: Fluorescence readings of FAM labelled oligonucleotide.</figcaption> |
</br> | </br> | ||
<img src="https://static.igem.org/mediawiki/2015/0/0c/2015-Glasgow-interlab8.png" height="60%" width="60%"/> | <img src="https://static.igem.org/mediawiki/2015/0/0c/2015-Glasgow-interlab8.png" height="60%" width="60%"/> | ||
− | <figcaption>Figure 6: Confirmation of linear relationship between FAM labelled oligonucleotide concentration and measured fluorescence on the Typhoon. Gradient of this calibration curve is the conversion factor for fluorescence as measured by the Typhoon to equivalent pmol of FAM labelled oligo.</figcaption> | + | <figcaption><b>Figure 6</b>: Confirmation of linear relationship between FAM labelled oligonucleotide concentration and measured fluorescence on the Typhoon. Gradient of this calibration curve is the conversion factor for fluorescence as measured by the Typhoon to equivalent pmol of FAM labelled oligo.</figcaption> |
</div> | </div> | ||
</div> | </div> | ||
Line 555: | Line 595: | ||
</br></br> | </br></br> | ||
+ | <h2>Sequencing</h2> | ||
+ | <div class="box"> | ||
+ | <h5>J23101:I13504</h5> | ||
+ | <div class="text"> | ||
+ | </br> | ||
+ | Plasmid Map: | ||
+ | </br> | ||
+ | </figure></center> | ||
+ | <br> | ||
+ | <center><figure> <img src=" https://static.igem.org/mediawiki/2015/5/54/2015-Glasgow-interlab30.png"> | ||
+ | </br> | ||
+ | </br> | ||
+ | <a href="https://static.igem.org/mediawiki/2015/f/f0/2015-Glasgow-interlab34.pdf" target="_blank">Sequencing results can be found here</a> | ||
+ | </div> | ||
+ | </div> | ||
+ | </br> | ||
+ | <div class="box"> | ||
+ | <h5>J23106:I13504</h5> | ||
+ | <div class="text"> | ||
+ | </br> | ||
+ | Plasmid Map: | ||
+ | </br> | ||
+ | </figure></center> | ||
+ | <br> | ||
+ | <center><figure> <img src="https://static.igem.org/mediawiki/2015/4/48/2015-Glasgow-interlab31.png"> | ||
+ | </br> | ||
+ | </br> | ||
+ | <a href="https://static.igem.org/mediawiki/2015/f/f0/2015-Glasgow-interlab34.pdf" target="_blank">Sequencing results can be found here</a> | ||
+ | </div> | ||
+ | </div> | ||
+ | </br> | ||
+ | <div class="box"> | ||
+ | <h5>J23117:I13504</h5> | ||
+ | <div class="text"> | ||
+ | </br> | ||
+ | Plasmid Map: | ||
+ | </br> | ||
+ | </figure></center> | ||
+ | <br> | ||
+ | <center><figure> <img src="https://static.igem.org/mediawiki/2015/8/87/2015-Glasgow-interlab32.png"> | ||
+ | </br> | ||
+ | </br> | ||
+ | <a href="https://static.igem.org/mediawiki/2015/f/f0/2015-Glasgow-interlab34.pdf" target="_blank">Sequencing results can be found here</a> | ||
+ | </div> | ||
+ | </div> | ||
+ | </br> | ||
+ | |||
+ | <div class="scrolldiscuss"></div> | ||
+ | </br> | ||
<h2>Measurements</h2> | <h2>Measurements</h2> | ||
<div class="box"> | <div class="box"> | ||
− | <h5>Direct Measurement | + | <h5>Direct Measurement </h5> |
<div class="text"> | <div class="text"> | ||
</br> | </br> | ||
The A600 of each device colony 1-3 and technical replicates were measured along with the controls (table 4). | The A600 of each device colony 1-3 and technical replicates were measured along with the controls (table 4). | ||
</br> | </br> | ||
− | <img src="https://static.igem.org/mediawiki/2015/d/d0/2015-Glasgow-interlab9.png"> | + | </figure></center> |
− | <figcaption>Table 4: Absorbance at 600nm for each biological and technical replicates of the devices and controls. Units are arbitrary.</figcaption> | + | <br> |
+ | <center><figure> <img src="https://static.igem.org/mediawiki/2015/d/d0/2015-Glasgow-interlab9.png"> | ||
+ | <figcaption><b>Table 4</b>: Absorbance at 600nm for each biological and technical replicates of the devices and controls. Units are arbitrary.</figcaption> | ||
</br> | </br> | ||
</br> | </br> | ||
− | The fluorescence was also measured (figure 7) and the resulting images converted to numerical readings (table 5). | + | <p align="left">The fluorescence was also measured (figure 7) and the resulting images converted to numerical readings (table 5).</p> |
</br> | </br> | ||
<img src="https://static.igem.org/mediawiki/2015/7/75/2015-Glasgow-interlab10.png" height="70%" width="70%"/> | <img src="https://static.igem.org/mediawiki/2015/7/75/2015-Glasgow-interlab10.png" height="70%" width="70%"/> | ||
− | <figcaption>Figure 7: Fluorescence results of the three devices and the positive and negative controls. A. Shows the image at low brightness to compare the J23101 and J23106 devises. B. Shows the image at high brightness to compare the J23117 device with the two brighter devices.</figcaption> | + | <figcaption><b>Figure 7</b>: Fluorescence results of the three devices and the positive and negative controls. A. Shows the image at low brightness to compare the J23101 and J23106 devises. B. Shows the image at high brightness to compare the J23117 device with the two brighter devices.</figcaption> |
</br> | </br> | ||
<img src="https://static.igem.org/mediawiki/2015/9/9d/2015-Glasgow-interlab23.png" height="60%" width="60%"/> | <img src="https://static.igem.org/mediawiki/2015/9/9d/2015-Glasgow-interlab23.png" height="60%" width="60%"/> | ||
− | <figcaption>Table 5: Summary of fluorescence data measured for the three devices and controls.</figcaption> | + | <figcaption><b>Table 5</b>: Summary of fluorescence data measured for the three devices and controls.</figcaption> |
</div> | </div> | ||
</div> | </div> | ||
</br> | </br> | ||
<div class="box"> | <div class="box"> | ||
− | <h5>Derived Measurements | + | <h5>Derived Measurements </h5> |
<div class="text"> | <div class="text"> | ||
</br> | </br> | ||
1. The average background absorbance was removed by subtracting the average of the empty wells with no PBS or sample (423,343.279). | 1. The average background absorbance was removed by subtracting the average of the empty wells with no PBS or sample (423,343.279). | ||
</br> | </br> | ||
− | 2. The average absorbance of control E.coli cells was removed by subtracting the average of the TOP 10 cells with R0040 (222,475). | + | 2. The average absorbance of control <i>E.coli</i> cells was removed by subtracting the average of the TOP 10 cells with R0040 (222,475). |
</br> | </br> | ||
3. These values were divided by the absorbance values at 600nm to give the fluorescence per OD 600 in arbitrary units (Table 6). | 3. These values were divided by the absorbance values at 600nm to give the fluorescence per OD 600 in arbitrary units (Table 6). | ||
Line 588: | Line 679: | ||
4. Dividing these values by the conversion factor as determined from the FAM oligo dilutions (479,000) gives the absolute fluorescence equivalent to pmol of FAM oligo per A600 of cells (Table 6). | 4. Dividing these values by the conversion factor as determined from the FAM oligo dilutions (479,000) gives the absolute fluorescence equivalent to pmol of FAM oligo per A600 of cells (Table 6). | ||
</br> | </br> | ||
− | <img src="https://static.igem.org/mediawiki/2015/f/ff/2015-Glasgow-interlab21.png" height="70%" width="70%"/> | + | </figure></center> |
− | <figcaption>Table 6: Derived measurements of devices and controls. | + | <br> |
− | + | <center><figure> <img src="https://static.igem.org/mediawiki/2015/f/ff/2015-Glasgow-interlab21.png" height="70%" width="70%"/> | |
− | + | <figcaption><b>Table 6</b>: Derived measurements of devices and controls.</figcaption> | |
− | + | ||
</br> | </br> | ||
</div> | </div> | ||
Line 603: | Line 693: | ||
We attempted to estimate the absolute number of GFP molecules per cell (Table 7) using our phiLOV results and some simplifying assumptions. | We attempted to estimate the absolute number of GFP molecules per cell (Table 7) using our phiLOV results and some simplifying assumptions. | ||
</br> | </br> | ||
− | <img src="https://static.igem.org/mediawiki/2015/9/98/2015-Glasgow-Interlab24.png" height="70%" width="70%"/> | + | </figure></center> |
− | <figcaption> Table 7: Summary of absolute number of GFP molecules per cell.</figcaption> | + | <br> |
− | In order to estimate the absolute number of GFP molecules per cell the following calculations were carried out: | + | <center><figure> <img src="https://static.igem.org/mediawiki/2015/9/98/2015-Glasgow-Interlab24.png" height="70%" width="70%"/> |
+ | <figcaption> <b>Table 7</b>: Summary of absolute number of GFP molecules per cell.</figcaption> | ||
+ | <p align="left">In order to estimate the absolute number of GFP molecules per cell the following calculations were carried out: | ||
</br> | </br> | ||
− | < | + | <p align="left">ilov stock = 1.35 mg/ml = 1.35 g/l |
</br> | </br> | ||
− | < | + | <p align="left">MW = approx. 150x110 = 16500 |
</br> | </br> | ||
− | < | + | <p align="left">ilov stock = 82uM |
</br> | </br> | ||
− | < | + | <p align="left">Avogadro’s number = 6.02x10^23 |
</br> | </br> | ||
− | ⇒ Diluted stock 2 fold and used 100 ul in well = 1/20000 litre = 4.1 nmoles | + | <p align="left">⇒ Diluted stock 2 fold and used 100 ul in well = 1/20000 litre = 4.1 nmoles |
</br> | </br> | ||
− | ⇒ 4.1 nmoles of phiLOV gave a reading of 490,000,000 | + | <p align="left">⇒ 4.1 nmoles of phiLOV gave a reading of 490,000,000<p> |
</br> | </br> | ||
Line 636: | Line 728: | ||
</br> | </br> | ||
⇒ 1 OD600 of TOP10 = 4x10^8 cells per 200 ul | ⇒ 1 OD600 of TOP10 = 4x10^8 cells per 200 ul | ||
− | <ul><li> So 1 cell contains 4.4 x 10^14 / 4 x10^8 = 1 million copies of GFP</li></ul> | + | <ul><li> So 1 cell contains 4.4 x 10^14 / 4 x10^8 = <b>1 million copies of GFP</b></li></ul> |
</br> | </br> | ||
⇒ 1 million molecules of GFP = (1000000/6.02x10^23) = 1.7x10^-18 moles GFP | ⇒ 1 million molecules of GFP = (1000000/6.02x10^23) = 1.7x10^-18 moles GFP | ||
Line 642: | Line 734: | ||
</br> | </br> | ||
⇒ typical total protein content of bacterial cell = 100 femto grams | ⇒ typical total protein content of bacterial cell = 100 femto grams | ||
− | <ul><li> So approximately half of all cellular protein is GFP</li></ul> | + | <ul><li> So <b>approximately half of all cellular protein is GFP</b></li></ul> |
</div> | </div> | ||
</div> | </div> | ||
Line 660: | Line 752: | ||
</br> | </br> | ||
⇒ 1 OD600 of TOP10 = 4x10^8 cells per 200 ul | ⇒ 1 OD600 of TOP10 = 4x10^8 cells per 200 ul | ||
− | <ul><li> So 1 cell contains 1.08x10^14 / 4 x10^8 = 272,405 = 270,000 copies of GFP</li></ul> | + | <ul><li> So 1 cell contains 1.08x10^14 / 4 x10^8 = 272,405 = <b>270,000 copies of GFP</b></li></ul> |
</br> | </br> | ||
⇒ 270,000 molecules of GFP = (270,000/6.02x10^23) = 4.48x10^-19 moles GFP | ⇒ 270,000 molecules of GFP = (270,000/6.02x10^23) = 4.48x10^-19 moles GFP | ||
Line 666: | Line 758: | ||
</br> | </br> | ||
⇒ typical total protein content of bacterial cell = 100 femto grams | ⇒ typical total protein content of bacterial cell = 100 femto grams | ||
− | <ul><li> so 12% of cellular protein is GFP</li></ul> | + | <ul><li> so <b>12% of cellular protein is GFP</b></li></ul> |
</div> | </div> | ||
</div> | </div> | ||
Line 686: | Line 778: | ||
</br> | </br> | ||
⇒ 1 OD600 of TOP10 = 4x10^8 cells per 200 ul | ⇒ 1 OD600 of TOP10 = 4x10^8 cells per 200 ul | ||
− | <ul><li> So 1 cell contains 1.08 x 10^12 / 4 x10^8 = 2,700 copies of GFP</li></ul> | + | <ul><li> So 1 cell contains 1.08 x 10^12 / 4 x10^8 = <b>2,700 copies of GFP</b></li></ul> |
</br> | </br> | ||
⇒ 1 million molecules of GFP = (2,700/6.02x10^23) = 4.48x10^-21 moles GFP | ⇒ 1 million molecules of GFP = (2,700/6.02x10^23) = 4.48x10^-21 moles GFP | ||
Line 692: | Line 784: | ||
</br> | </br> | ||
⇒ typical total protein content of bacterial cell = 100 femto grams | ⇒ typical total protein content of bacterial cell = 100 femto grams | ||
− | <ul><li> so 1.2x10^-3 % of all cellular protein is GFP</li></ul> | + | <ul><li> so <b>1.2x10^-3 % of all cellular protein is GFP</b></li></ul> </p> |
</div> | </div> | ||
Line 698: | Line 790: | ||
</div> | </div> | ||
</div> | </div> | ||
− | <div class=" | + | <div class="scrollcontamination"></div> |
</br> | </br> | ||
</br> | </br> | ||
− | + | ||
+ | |||
+ | |||
+ | |||
+ | |||
+ | <h2>Conclusion</h2> | ||
+ | <center> | ||
+ | <p class="mainText"> | ||
+ | Our measurements have shown that promoters J23101 and J23106 produce more fluorescence with I13504 than the known GFP part I20270 and J23117 shows far less fluoresence, with measurements closer to the negative control R0040 (Figure 8). | ||
+ | </br> | ||
+ | <br> | ||
+ | <center><figure><img src="https://static.igem.org/mediawiki/2015/0/0d/2015-Glasgow-interlab100.png"> | ||
+ | <figcaption><b>Figure 8</b> Mean and standard deviation (error bars) for each device and sample.</figcaption></center> | ||
+ | |||
+ | |||
+ | </br> | ||
+ | |||
+ | |||
<h2>References</h2> | <h2>References</h2> | ||
Line 708: | Line 817: | ||
</br> | </br> | ||
<div style="visibility:hidden; height:0;width:0;" class="scrollSurvivability"></div> </p> | <div style="visibility:hidden; height:0;width:0;" class="scrollSurvivability"></div> </p> | ||
− | |||
− | |||
− | |||
+ | </div> | ||
<script> | <script> | ||
Latest revision as of 23:57, 13 November 2015
Interlab Study
Home > Measurement > Interlab Study
Overview
All 2015 iGEM teams have been invited to participate in the Second International InterLab Measurement Study in synthetic biology. Each lab will obtain fluorescence data for the same three GFP-coding devices with different promoters varying in strength. The objective is to assess the robustness of standard parts and the variability of measurements among different research groups using different lab techniques.
Introduction
This year iGEM Glasgow have participated in the InterLab study and Extra Credit. The three devices required were cloned, as specified, and using a plate reader measurements were obtained in absolute units in terms of moles of FAM labelled oligonucleotide.
Release
Individuals responsible for conducting InterLab study
Others who should be credited, e.g., in a publication based on this data
Dates of InterLab Study
Detailed Lab Book
Equipment
Equipment used to acquire measurements
o Incubator – 2cm shaking diameter o BioMate™ 3S Spectrophotometer: Life Science Analyzer – Used to measure absorbance at 600nm of each sample. o Typhoon FLA 9500: GE Healthcare Life Sciences - Wavelength used to excite cells - 475nm. Filter/channel used to capture the light emission from the cells - Filter BPB1 (530DF20).
Spectrophotometer calibration
Typhoon FLA 9500 calibration
Methodology
Protocol for cloning devices
Preparation for measurements
Protocol for measurements
The controls
Protocol for calculating a conversion factor for absolute units
Sequencing
J23101:I13504
J23106:I13504
J23117:I13504
Measurements
Direct Measurement
Derived Measurements
Estimation of absolute number of GFP molecules per cell
Conclusion
Our measurements have shown that promoters J23101 and J23106 produce more fluorescence with I13504 than the known GFP part I20270 and J23117 shows far less fluoresence, with measurements closer to the negative control R0040 (Figure 8).
References
Buckley, A. Petersen, J. Roe, A. Douce, G. Christie, J. (2015). LOV-based reporters for fluorescence imaging. Current Opinion in Chemical Biology. 27 (1), p39–45.